stars 1 stars 2 stars 3

The INSERM U1070 unit aim to optimize the antibiotic usage with a triple target: To increase their efficacy, To control the toxicity and To limit the emergence of antibiotic resistance. In order to do so, we are developping innovative PK/PD modelling approaches to select the best dosing regimen of antibiotics administered alone or in combination as well as the best route of administration and best formulation.

Website https://phar.labo.univ-poitiers.fr/
Revenue $494 million
Employees 13 (5 on RocketReach)
Founded 2012
Address 1, Rue Georges Bonnet, Poitiers, Nouvelle-Aquitaine 86000, FR
Industry Think Tanks

Inserm U1070 Questions

The Inserm U1070 annual revenue was $494 million in 2026.

5 people are employed at Inserm U1070.

Inserm U1070 is based in Poitiers, Nouvelle-Aquitaine.

Top Inserm U1070 Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users